FundLens
31
Pharma & HealthcareAvoid

LIC MF Healthcare

LIC · Direct–Growth · rank #16 of 19 by Smart Score

Data updated

Trailing returns

vs Nifty 500 (index-fund proxy)
1 Year
18.3%
+17.6% vs index
3 Years
21.4%
+9.9% vs index
5 Years
14.8%
+4.7% vs index
Since launch
19.2%

Year-by-year performance

last entry = YTD
2024
+43.9%
2025
-3.2%
2026
+21.4%

Why this score

LIC MF Healthcare scores 31/100 — #16 of 19 Pharma & Healthcare fund (Avoid). The main drag is its 5y return (better than only 5% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

5Y return14.76% · 5th percentile in category
Fund size96.69 Cr · 3rd percentile in category
Expense ratio1.38% · 14th percentile in category
Volatility16.16 · 28th percentile in category
Alpha2.60 · 28th percentile in category
1Y return18.31% · 32nd percentile in category

Top holdings

top 5 = 33.7% of portfolio
1.Sun Pharmaceutical Industries Ltd8.65%
2.Divi's Laboratories Ltd7.09%
3.Apollo Hospitals Enterprise Ltd6.13%
4.Torrent Pharmaceuticals Ltd5.97%
5.Neuland Laboratories Ltd5.83%

27 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.

Other Pharma & Healthcare funds